TD Cowen analyst Andrew Kligerman maintained a Buy rating on Abacus Life (ABL – Research Report) today and set a price target of $14.00. The ...

TD Cowen analyst Phil Nadeau maintained a Buy rating on Rhythm Pharmaceuticals (RYTM – Research Report) today. The company’s shares opened ...

El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...

Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, describes the current market as "choppy," indicating the need for careful navigation. She emphasizes the importance of ...

Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, discusses some of the key findings of a new TD Cowen report on the big investment themes of 2025, including shifting ...

Calling people "mentally ill" based on their sexual identity and referring to women as "household objects" will now be allowed in the context of political discussions on social media giant Meta's ...